Replies to post #336789 on Amarin Corp Plc (AMRN)

[couldbebetter]

Curfman has an agenda. No mention of the Evaporate trial which proves
MO to be a valid placebo. Does Curfman question the validity of Corn
oil as a placebo? Once again, AMRN must be placed in BP hands before
this agenda against AMRN destroys it!

[zmanindc]

Maybe we can get Bhatt to publish a rebuttal.

[studythosestocks]

. A direct comparison of icosapent ethyl with corn
oil in a new randomised clinical trial would settle the
matter, but it seems unlikely that Amarin would undertake such an expensive trial, especially in the light of
the invalidation of its patents and probable diminution
of the US market for Vascepa. Still, patients and physicians need to know whether icosapent ethyl has cardiovascular health benefits, and FDA should mandate a
clinical trial to answer the question.

I didn't agree with everything he said in the early parts of the article but at least he understood we were robbed of our patents with at least two statistical blunders that our defense team didn't discover and bring to light.

Once he went down the Mineral Oil Conspiracy path, I just started shaking my head. I'm so tired of this song being sung off key. If he really understood Vascepa how can he even believe this??!! Why did the subgroups from Reduce-IT show those with higher EPA levels show even a greater benefit from Vascepa? If it was the mineral oil then it wouldn't matter what your EPA levels were, the results would be the same. Didn't Evaporate give him some type of idea what might be happening here? Just dumb is a dumb does.

This can't catch momentum in Europe. It just can't.

We've got at least the European Society of Cardiology and the European Atherosclerosis Society recommending the use of Vaskepa in Europe as soon as available for its intended medical uses.

It's clear from our press release on EU role out as well that preventative medicine is going to be our focus in our role out.

Momentum is everything when it comes to drug sales. Make Germany the poster child for effective marketing and the rest of Europe will follow.

I naively believe we can.

JMO